Ching-Lan Cheng

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Community Acquired Pneumonia

Acute Coronary Syndrome

Molecularly Imprinted

Top Venues

Journal of medical Internet research

Pharmacoepidemiology and drug safety

National Cheng Kung University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

National Cheng Kung University

Taiwan

PHD :: Institute of Pharmaceutical Sciences

Publications

Yi-Chia Su, Chih-Chien Wu, Chien-Chou Su, Meng-Che Hsieh, Ching-Lan Cheng, Yea-Huei Kao Yang
Comparative Effectiveness of Bevacizumab versus Cetuximab in Metastatic Colorectal Cancer Patients without Primary Tumor Resection. Cancers 14 (9) (2022)
Ching-Fen Shen, Ju-Ling Chen, Chien-Chou Su, Wen-Liang Lin, Min-Ling Hsieh, Ching-Chun Liu, Ching-Lan Cheng
Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan. Vaccines 9 (9) (2021)
Kelly Huang, Ching-Lan Cheng, Yea-Huei Kao Yang
Not all aspirin products have equivalent antiplatelet efficacy-Aspirin formulated with magnesium stearate is less effective in preventing ischemic stroke. Pharmacoepidemiology and drug safety 29 (12) (2020)
Chi-Shiang Wang, Pei-Ju Lin, Ching-Lan Cheng, Shu-Hua Tai, Yea-Huei Kao Yang, Jung-Hsien Chiang
Detecting Potential Adverse Drug Reactions Using a Deep Neural Network Model. Journal of medical Internet research 21 (2) (2019)